11/01/2017
This evaluation was conducted by Andrew McKenzie and Timothy McCann on behalf of the Stockholm Evaluation Unit of MSF

SSP was formed in the aftermath of a high profile depot crisis in South Africa in 2012/3, with six organisations, already dealing with drug stock outs joining forces to tackle the issue. The different organisations brought different skills to the table. Largely focused on anti-retrovirals (ARVs) and TB medication, from the beginning the SSP has tasked itself to hold government accountable, to perform a watchdog role and to present the patient view on stock outs. This evaluation shows the impact of the SSP since inception and identifies best ways to capitalise on the early success of the project. 

Full Report 

Short Version